Well, maybe, … at least among men living in in the Miyagi and Ohsaki prefectures, in Japan. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Japan, mushrooms, Prevention, risk | Leave a comment »
-
-
-
-
-
-
- The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of
Awards
Other PCI web sites
-
PCaI’s ASVSG
If you are on or thinking about active surveillance (AS) as a way to manage your low-risk prostate cancer, you may want to join Prostate Cancer International’s Active Surveillance Virtual Support Group.
CureTalks on PCa
Our most recent CureTalk on Prostate Cancer (on February 21 this year) features Eli Van Allen, MD, of the Broad Institute and the Dana-Farber Cancer Center, talking about the new “Metastatic Prostate Cancer Project” and how you can become part of the solution.
For access to the full list of CureTalks on Prostate Cancer, please click here.
Disclaimer
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
-
Hot Posts …
- Complementary and alternative medicines in management of prostate cancer
- Come to Virginia Beach in November to expand your minds
- Lifestyle, diet, exercise, and cancer
- Does eating mushrooms prevent prostate cancer?
- The APCCC in Basel, Switzerland: where to get the details
- High-dose vitamin D: negative results from a randomized clinical trial
- The APCCC in Basel, Switzerland: Day 3
- The APCCC in Basel, Switzerland: Day 2
- The APCCC in Basel, Switzerland: Day 1
- Adjuvant chemotherapy does NOT improve BDFS rates in men with intermediate- and high-risk prostate cancer
- FDA approves new technique for “ablation of prostate tissue”
- The definition of a SECOND biochemical recurrence (after prostatectomy AND salvage radiation)
- Imaging studies for men with recurrent prostate cancer
- PARP inhibitor has positive outcomes in Phase III trial in selected men with mCRPC
- Are “manograms” a viable option in prostate cancer screening and risk assessment?
… and Archives
Blog at WordPress.com. WP Designer.
